ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and clinical development of treatments for central nervous system disorders utilizing its R-SAT technology. It has five Phase II-stage clinical programs, as well as a port
- Product Details
- Brand :
- Place of Origin : Not Given
- FOB Price : On Request
- Minimum Order Quantity : Not Given
- Supply Ability :
- Packaging & Delivery
- Packaging Detail : Not Given
- Delivery Detail : Not Given
Not Given
Other Products
and then add to homescreen